Target intelligence / Profile preview

Vitamin K–dependent clotting factor (null)

Target
null
Molecular classification
Enzyme substrate (coagulation cascade protein), Plasma protein, Other
01

Overview

“Vitamin K–dependent clotting factor” is a collective, not singular, term describing a group of plasma proteins essential for the normal clotting (coagulation) process in blood. These proteins require post-translational gamma-carboxylation of specific glutamic acid (Glu) residues, a reaction that depends on vitamin K as a cofactor, to acquire calcium-binding capability and full biological activity. The classical vitamin K–dependent clotting factors are **Factor II (prothrombin)**, **Factor VII**, **Factor IX**, and **Factor X**. Additionally, **protein C**, **protein S**, and *protein Z* are vitamin K–dependent proteins with regulatory (anticoagulant) or other roles. These proteins play key roles in the coagulation cascade: procoagulant factors initiate and propagate clot formation, while anticoagulant proteins regulate or prevent excessive clotting. Deficiency or pharmacological inhibition (e.g., with warfarin) of vitamin K leads to undercarboxylation, dysfunctional clotting factors, and increased bleeding risk. Monitoring is done via PT/INR assays and/or individual factor assays. The term “Vitamin K–dependent clotting factor” itself is not a unique molecular entity but a functional group, and should be further specified (e.g., “Prothrombin (Factor II)”) when describing a therapeutic or biochemical target[1][3][4][5][6][7][9]. **Important note:** As written, “Vitamin K dependent clotting factors” is collective and does not refer to one unique molecule, but several proteins (most importantly Factors II, VII, IX, X, and also protein C, S, and Z). For research and database purposes, it is strongly recommended to specify the exact factor if possible. **is_incorrect:** true, as this term is non-specific for a molecular target.

Other names
Vitamin K–dependent coagulation factorVKD clotting factorVitamin K–dependent plasma protein
02

Mechanism of action

Inhibitors (e.g., warfarin) block vitamin K epoxide reductase, preventing gamma-carboxylation, thus reducing activation of these clotting factors[6][1][4] Supplementation of vitamin K restores gamma-carboxylation and function

03

Biological functions

Blood coagulation (hemostasis)Regulation of clot formation and dissolutionCalcium ion binding (enables cascade activation)[3][4][5]Vascular homeostasis
04

Disease associations

Cardiovascular disease (thrombosis, hemorrhagic disorders)[7]Other (hereditary bleeding disorders, liver disease-related deficiency)
05

Safety considerations

Excessive inhibition (anticoagulation) increases bleeding risk[6]Underactivation (deficiency or antagonism) can lead to hemorrhage[5]Vitamin K–dependent antagonist use requires careful monitoring (INR)
06

Interacting drugs

Warfarin

4 more in the full profile.

07

Biomarkers

Prothrombin time (PT)International normalized ratio (INR)Levels or activity of individual clotting factors (e.g., Factor II, VII, IX, X)[5]Proteins C and S levels

Beyond the preview

Go deeper on Vitamin K–dependent clotting factor (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vitamin K–dependent clotting factor (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call